Go to:
Logótipo
Você está em: Start » Courses/CE or Courses/Cycle of Studies or Programmes/Cycle of Studies » PDMOM

Courses

Molecular Medicine and Oncology

InformationCourse/CS accredited by the Agency for Assessment and Accreditation of Higher Education (A3ES).

The PhD Program in Medicine and Molecular Oncology is the result of collaboration between the two medical schools of U.Porto (FMUP and ICBAS) and some of the main national health research centers.

This 3rd Cycle of Studies is essentially intended for medical doctors, dentists, and veterinarians and seeks to prepare medical scientists who wish to integrate medical knowledge with Molecular Biology, applying them to diagnosis, therapy, and prognosis.

The study plan comprises an initial academic component, which includes core and optional course units, and the development of an original research project. Throughout the Program, which lasts four years and totals 210 ECTS, students also have access to seminars, sessions of a general nature or focused on specific scientific problems, as well as courses and internships at different institutions.

 


Tuition Fee p/ academic year:
Nacional: 2750¤
International: 7500¤
CPLP International: 4125¤


SINGULAR CURRICULAR UNITS (see here)



Contacts

Postgraduate Education Unit

Telf: (+351) 220 426 976
 E: posgraduacao@med.up.pt


E-mail of the PhD programme: mom@med.up.pt

General information

Official Code: 5196
Director: Henrique Almeida
Acronym: PDMOM
Academic Degree: Doctor
Type of course/cycle of study: Doctoral Degree
Start: 2007/2008
Duration: 4 Years

Study Plan

Involved Organic Units

Certificates

  • Molecular and Oncology Medicine (240 ECTS credits)
  • Molecular and Oncology Medicine (210 ECTS credits)
  • Molecular and Oncology Medicine (30 ECTS credits)
  • Molecular Medicine and Oncology (30 ECTS credits)

Predominant Scientific Areas

Recommend this page Top
Copyright 1996-2024 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Last update: 2023-02-22 I  Page created on: 2024-04-20 at 04:27:20
Acceptable Use Policy | Data Protection Policy | Complaint Portal | Política de Captação e Difusão da Imagem Pessoal em Suporte Digital